Elevance Health Inc.ELVNYSE

Overview Intelligence Charts News Fundamentals

Analyst Sentiment

Analysts lean bullish — 75% recommend buying.

Consensus Rating

Buy

24 analysts·High coverage

75%

Rating Distribution

Strong Buy

00%

Buy

1875%

Hold

625%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 36% higher.

Bear Case

$332.00

+17%

Consensus

$387.14

+36%

Bull Case

$425.00

+50%

Price Range24 analysts

Low

Consensus

High

$332.00

$425.00

Current Target

Current Price

$284.03

Upside to Target

$103.11

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$25.99(15 analysts)

P/E11x

Current: 11.1x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+2.90%

EPS+13.28%

FY2028

Rev+4.40%

EPS+19.49%

FY2029

Rev+7.29%

EPS+29.61%

Earnings Surprises

Beat rate:83%(10/12 quarters)

Avg surprise:+3.0%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Feb 3, 2026RBC Capital

Elevance Health downgraded to Sector Perform from Outperform at RBC Capital

Target:$358.00

+4.7%from $341.83

Feb 2, 2026Truist Financial

Elevance Health price target lowered to $390 from $400 at Truist

Target:$390.00

+14.3%from $341.29

Feb 2, 2026Craig-Hallum

Elevance (ELV) PT Lowered to $409 at Bernstein

Target:$409.00

+20.1%from $340.68

Feb 2, 2026Piper Sandler

Elevance (ELV) PT Lowered to $409 at Bernstein

Target:$409.00

+20.1%from $340.68

Feb 1, 2026Bernstein

Elevance Health price target lowered to $409 from $431 at Bernstein

Target:$409.00

+18.3%from $345.74

Jan 30, 2026Wells Fargo

Elevance Health price target lowered to $391 from $424 at Wells Fargo

Target:$391.00

+12.7%from $346.98

Jan 30, 2026Barclays

Elevance Health price target lowered to $393 from $404 at Barclays

Target:$393.00

+13.3%from $346.98

Jan 29, 2026UBS

Elevance Health price target lowered to $400 from $425 at UBS

Target:$400.00

+15.9%from $345.27

Jan 29, 2026Deutsche Bank

Elevance Health price target raised to $332 from $320 at Deutsche Bank

Target:$332.00

-3.8%from $345.22

Jan 29, 2026Guggenheim

Elevance Health price target lowered to $396 from $414 at Guggenheim

Target:$396.00

+15.8%from $341.85

Jan 22, 2026Guggenheim

Elevance Health price target raised to $414 from $398 at Guggenheim

Target:$414.00

+11.9%from $369.88

Jan 9, 2026Mizuho Securities

Elevance Health price target raised to $413 from $400 at Mizuho

Target:$413.00

+10.2%from $374.77

Jan 8, 2026Wolfe Research

Elevance Health upgraded to Outperform from Peer Perform at Wolfe Research

Target:$425.00

+15.9%from $366.69

Jan 7, 2026Wells Fargo

Elevance Health price target raised to $424 from $403 at Wells Fargo

Target:$424.00

+14.2%from $371.37

Jan 6, 2026Bernstein

Elevance Health price target raised to $431 from $412 at Bernstein

Target:$431.00

+17.0%from $368.51

Jan 5, 2026Barclays

Elevance Health price target raised to $404 from $385 at Barclays

Target:$404.00

+14.0%from $354.25

Dec 19, 2025Deutsche Bank

Elevance Health downgraded to Hold from Buy at Deutsche Bank

Target:$320.00

-7.1%from $344.60

Dec 18, 2025Morgan Stanley

Elevance Health price target lowered to $352 from $359 at Morgan Stanley

Target:$352.00

+1.7%from $345.96

Nov 3, 2025Mizuho Securities

Elevance Health price target lowered to $400 from $420 at Mizuho

Target:$400.00

+27.7%from $313.19

Oct 22, 2025Barclays

Elevance Health price target lowered to $385 from $395 at Barclays

Target:$385.00

+13.0%from $340.76

Oct 21, 2025Bernstein

Bernstein SocGen Group Reiterates Outperform Rating on Elevance (ELV)

Target:$420.00

+20.5%from $348.48

Oct 14, 2025Truist Financial

Elevance Health price target raised to $400 from $365 at Truist

Target:$400.00

+14.9%from $348.16

Oct 14, 2025Morgan Stanley

Elevance Health price target raised to $359 from $316 at Morgan Stanley

Target:$359.00

+2.8%from $349.16

Oct 14, 2025Goldman Sachs

Elevance Health initiated with a Neutral at Goldman Sachs

Target:$343.00

-2.4%from $351.42

Oct 9, 2025Mizuho Securities

Elevance Health price target raised to $420 from $342 at Mizuho

Target:$420.00

+15.9%from $362.34

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance